Key Metrics of Nocil Limited
About Nocil Limited
Company details
- Registered office
- Mafatlal House, H T Parekh Marg, Backbay Reclamation, Churchgate, Mumbai, In-mh, 400020
- Listed
- NSE: NOCIL · ₹146.70
Company summary
Entity details
Compliance
Industry classification
Financials, ratios and risk analysis
Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Credit ratings
Rating history
Rating actions
| Date | Agency | Action | Long term | Short term | Outlook | Rated amount | Rationale |
|---|---|---|---|---|---|---|---|
| 03 Oct 2025 | CARE | Reaffirmed | AA | A1+ | Stable | ₹700 Cr | View |
| 26 Dec 2024 | CARE | Other | — | — | — | — | View |
| 09 Oct 2023 | CARE | Other | — | — | — | — | View |
| 30 Aug 2022 | CARE | Reaffirmed | AA | A1+ | Stable | ₹500 Cr | View |
| 04 Jan 2022 | CARE | Reaffirmed | AA | A1+ | Stable | ₹200 Cr | View |
| 05 Jan 2021 | CARE | Reaffirmed | AA | A1+ | Stable | ₹400 Cr | View |
| 09 Mar 2020 | CARE | Reaffirmed | AA | A1+ | Stable | ₹400 Cr | View |
| 12 Mar 2019 | CARE | Reaffirmed | AA | A1+ | Stable | ₹200 Cr | View |
| 06 Mar 2019 | CARE | Other | — | — | — | — | View |
Credit strengths (CARE, Oct 2025)
+ Leadership position in the domestic rubber chemicals industry
NOCIL has over four decades of experience in manufacturing rubber chemicals. Over the years, it maintained a leadership position in the domestic rubber chemicals market with a product portfolio comprising over 20+ rubber chemicals. The company has an estimated market share of ~40% in the domestic rubber chemicals industry. Furthermore, the company has a presence in over 40 countries and enjoys long -standing relationships with its customers.
+ Liquidity: Strong
NOCIL’s liquidity continues to remain strong, marked by nil term debt repayment obligations in the near term, unutilised fund- based limits of ₹150 crore and healthy cash and liquid investments of ₹208 crore (excluding investments of ₹65 crore in unquoted FD) as on March 31, 2025. The company utilisesits non-based limits in the form of BG for procurement of raw materials, utilisation of which stood minimal at 2.65% in the last twelve months ended July 31, 2025. The company’s liquidity is further
Credit challenges
− Moderation in operating performance in FY25 and Q1FY26
NOCIL’s total operating income (TOI) declined by ~4% year-on-year (y-o-y) to ₹1392 crore in FY25, primarily due to a 9% y-o- y decline in overall realisations considering dumping led pricing pressure. Decline in revenue was partially offset by volume growth of 5% y-o-y, supported by strong growth of 12% y-o-y in export sales. Domestic volumes witnessed a modest growth of 2% y- o-y due to dumping from China, South Korea, Thailand and EU. Domestic sales contributed 64% to the total revenue in FY25
− Competition from cheap imports
NOCIL faces competitive pressure from dumping of rubber chemicals in the Indian market, mainly from China, South Korea, Thailand and EU. Being a major producer of rubber chemicals in the world, China contributes significantly to the global exports. Chinese and other Asian manufacturers benefit from lower production costs and economies of scale, leading to pricing pressure and reduced margins for domestic producers. Amidst large imports, the company has been maintaining competitive pricing to
− Profitability exposed to raw material price volatility
Most of NOCIL’s raw materials including benzene, chlorinated aromatics, and amines among others, are predominantly crude derivatives. Thus, raw material price volatility has a bearing on NOCIL’s profitability margins. NOCIL usually enters fixed-price volume contracts, for a quarter, with key customers, while remaining customers are contracted on a spot basis. There has been a declining trend in raw material prices for the company. However, higher decline in finished product prices, on the back o
− High dependence on automobile and tyre industry resulting in sector concentration risk
The automobile industry is the major consumer of rubber and rubber chemicals for manufacturing tyres and other auto components. It constitutes ~70-80% of rubber chemicals demand. NOCIL’s revenue thus remains exposed to performance of automobile and tyre industry. CareEdge Ratings expects stable domestic demand prospects for rubber chemicals, primarily backed 2 CARE Ratings Ltd. Press Release by stable demand prospects for tyres aided by replacement demand. Furthermore, recent reduction of GST ra
Could lead to an upgrade
• Substantial increase in global market share backed by improved exports, resulting in more diversified operations. • Sustained improvement in profit before interest, lease rentals, depreciation, and taxation (PBILDT) margin at more than 25%, while maintaining strong capital structure and
Could lead to a downgrade
• Significant reliance on debt for funding of growth plans leading to moderation in net debt/PBILDT beyond 1x on a sustained basis. • Changes in government regulations pertaining to production and sales of certain products, significantly impacting its business and profitability.
Agency-reported financials (CARE, 03 Oct 2025)
| Metric | Q1FY26 |
|---|---|
| Total operating income | ₹336 Cr |
| PBILDT | ₹30.58 Cr |
| PAT | ₹17.26 Cr |
| Overall gearing (times) | — |
| Interest coverage (times) | 82.65× |
| EBITDA margin | 9.1% |
| Implied interest cost (EBITDA ÷ coverage) | ₹0.37 Cr |
| PAT margin | 5.1% |
Borrowings & rated debt
Rated limits over time
Facility mix
Rated facilities
| Facility | Type | Previous | Current | Change | Rating | Action | Agency |
|---|---|---|---|---|---|---|---|
| Long-term bank facilities | Working capital & bank lines | — | ₹100 Cr | — | AA (Stable) | Assigned | CARE |
| Long-term bank facilities | Working capital & bank lines | — | ₹175 Cr | — | AA (Stable) | Reaffirmed | CARE |
| Short-term bank facilities | Working capital & bank lines | — | ₹425 Cr | — | A1+ | Reaffirmed | CARE |
CARE ratings on record (checked 23 Oct 2026)
| Instrument | Amount | Rating |
|---|---|---|
| BG/LC | ₹425 Cr | CARE A1+ |
| Commercial Paper (Carved out) | — | Withdrawn |
| Long Term | ₹175 Cr | CARE AA; Stable |
| Term Loan | — | Withdrawn |
| Term Loan | ₹100 Cr | CARE AA; Stable |
Lenders
| Fund-based | Long Term | Axis Bank Ltd. |
| Fund-based | Long Term | HDFC Bank Ltd. |
| Fund-based | Long Term | ICICI Bank Ltd. |
| Fund-based | Long Term | IDFC First Bank Ltd. |
| Fund-based | Long Term | Proposed |
| Fund-based - LT | Term Loan | Proposed |
| Non-fund-based - ST | BG/LC | Axis Bank Ltd. |
| Non-fund-based - ST | BG/LC | Citibank N A |
| Non-fund-based - ST | BG/LC | HDFC Bank Ltd. |
| Non-fund-based - ST | BG/LC | ICICI Bank Ltd. |
| Non-fund-based - ST | BG/LC | IDFC First Bank Ltd. |
Credit assessment · Manufacturing
Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26
Ratios, pillar scores and the indicative rating are part of Premium.
Rating status
| Default | No default on record |
| Issuer cooperation | Cooperating |
| Credit enhancement | None – standalone rating |
| Next action stable or better (model) | 83% |
| Information on file | 78% · missing: Capex / investment plans, Auditor details |
Indicative assessment from public data using the published methodology factors; not a credit rating.
Borrowing & funding lifecycle
- Credit outlook model: 83% chance the next rating action is stable or better
- Current rating AA (investment grade)
- Interest coverage 82.65×
Rated limits by facility
Timeline
From the report
Liquidity: Strong NOCIL’s liquidity continues to remain strong, marked by nil term debt repayment obligations in the near term, unutilised fund- based limits of ₹150 crore and healthy cash and liquid investments of ₹208 crore (excluding investments of ₹65 crore in unquoted FD) as on March 31, 2025.
From the report
Liquidity: Strong NOCIL’s strong liquidity is marked by unutilised fund based working capital limits of ₹150 crore and healthy free cash & liquid investments of ₹372 crore as on September 30, 2024.
From the report
NOCIL hardly utilises fund-based working capital limits, while average utilisation of non-fund-based limits stood minimal at ~10% in 12-months ended July 2024.
Lender names, bank charges and audited borrowings are part of Premium.
Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.
Registered office and contact
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.
